Ann: Significant Cardioprotection Qualities in AI-168 Studies, page-6

This reads well
in regard to Chemo

Animal study, never the less, they're making strides

In the third model, rat cardiomyoblasts were treated with doxorubicin. Doxorubicin is an anthracycline, which is an important class of chemotherapeutic drugs used for the treatment of several types of cancer. A known adverse effect of anthracycline treatment is chemotherapy-induced cardiotoxicity, which can occur during or after the completion of treatment. In this model, doxorubicin was shown to be toxic to the cardiomyoblasts, causing cell death and/or significantly reducing cell proliferation (Figure 3). By contrast, AI-168 restored approximately 68% of the cardiomyoblast growth lost to doxorubicin toxicity.